VOYDEYA Alexion Pharmaceuticals Australasia Pty Ltd
Product name
VOYDEYA
Accepted date
Aug-2023
Active ingredients
danicopan
Proposed indication
As an add-on for the treatment of the signs or symptoms of extravascular haemolysis (EVH) in adult patients with paroxysmal nocturnal haemoglobinuria (PNH).
Application type
A (new medicine)
Publication date
Aug-2023